# Cabenuva

NDC: 49702-253
Generic name: cabotegravir and rilpivirine
Labeler / Manufacturer: ViiV Healthcare Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: KIT
Routes: —
Marketing started: 20210121

FDA application: NDA212888

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49702-253"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49702-253
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1698baf3-f895-4c42-a1b1-e9ee3f20da36